A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant women

BMC Pregnancy and Childbirth

Volumn 15, Issue 1, 2015, Pages

  Regan, Annette K ^a,b   Tracey, Lauren ^b   Blyth, Christopher C ^a,c   Mak, Donna B ^b   Richmond, Peter C ^a,c   Shellam, Geoffrey ^a   Talbot, Caroline ^c   Effler, Paul V ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Communicable Disease Control Directorate   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antenatal immunisation; Pregnancy; Trivalent influenza vaccine; Vaccine safety

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CONTROLLED STUDY; FEMALE; FEVER; FOLLOW UP; GASTROENTERITIS; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; MALAISE; PREGNANT WOMAN; RIGOR; SELF REPORT; SPONTANEOUS ABORTION; TELEPHONE INTERVIEW; UPPER RESPIRATORY TRACT INFECTION; VACCINATION REACTION; ADULT; CASE CONTROL STUDY; CHEMICALLY INDUCED; COHORT ANALYSIS; COMPARATIVE STUDY; INFLUENZA, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDY; QUESTIONNAIRE; STATISTICAL MODEL; TEXT MESSAGING;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FEVER; HEADACHE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; TEXT MESSAGING;

EID: 84925853053     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/s12884-015-0495-2     Document Type: Article

References (22)

1. World Health Organisation. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec. 2012;87(47):461-6.
2. Taksdal SE, Mak DB, Joyce S, Tomlin S, Carcione D, Armstrong PK, et al. Predictors of uptake of influenza vaccination - a survey of pregnant women in Western Australia. Aust Fam Physician. 2013;42(8):585-6.
3. Wiley KE, Massey PD, Cooper SC, Wood NJ, Ho J, Quinn HE, et al. Uptake of influenza vaccine by pregnant women: a cross-sectional survey. Med J Aust. 2013;198(7):373-5.
4. Legge A, Dodds L, MacDonald NE, Scott J, McNeil S. Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes. Can Med Assoc J. 2014;186(4):E157-64.
5. Nordin JD, Kharbanda EO, Benitez GV, Lipkind H, Vellozi C, Destefano F. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Paediatr. 2014;164(5):1051-7.
6. Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway A, Lee G, Nordin JD. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol. 2013;122(3):659-67.
7. Haberg SE, Trogstad L, Gunnes N, Wilcox AJ, Gjessing HK, Samuelsen SO, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. New Engl J Med. 2013;368(4):333-40.
8. Naleway AL, Irving SA, Henninger ML, Li D-K, Shifflet P, Ball S, et al. Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies. Vaccine. 2014;32:3122-7.
9. Carcione D, Blyth CC, Richmond PC, Mak DB, Effler PV. Safety surveillance of influenza vaccine in pregnant women. Aust N Z J Obstet Gynaecol. 2013;53:98-103.
10. Regan AK, Blyth CC, Effler PV. Using SMS technology to verifty the safety of seasonal trivalent influenza vaccine for pregnant women in real time. Med J Aust. 2013;199(11):744-6.
11. Henninger M, Naleway A, Crane B, Donahue J, Irving S. Predictors of seasonal influenza vaccination during pregnancy. Obstet Gynecol. 2013;121(4):741-9.
12. Yuet Sheung Yuen C, Yee Tak Fong D, Lai Yin Lee I, Chu S, Sau-mei Siu E, Tarrant M. Prevalence and predictors of maternal seasonal influenza vaccination in Hong Kong. Vaccine. 2013;31(45):5281-8.
13. Bednarczyk RA, Adjaye-Gbewonyo D, Omer SB. Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol. 2012;207(3):S38-46.
14. Effler PV, Tomlin S, Joyce S, Mak DB. Adult preference for influenza vaccines with lower likelihood of side effects. Hum Vaccin Immunother. 2013;102:456-60.
15. Bartlett MJ, Burgess MA, McIntyre PB, Heath TC. Parent and general practitioner preferences for infant immunisation. Reactogencity or multiple injections? Aust Fam Physician. 1999;28 Suppl 1:S22-7.
16. Nordin JD, Kharbanda EO, Benitez GV, Nichol K, Lipkind H, Naleway A, et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol. 2013;121(3):519-25.
17. Moro PL, Broder K, Zheteyeva Y, Walton K, Rohan P, Sutherland A, et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting system, 1990-2009. Am J Obstet Gynecol. 2011;204(2):146. e141-147.
18. Fell DB, Dodds L, MacDonald NE, Allen VM, McNeil S. Influenza vaccination and fetal and neonatal outcomes. Expert Rev Vaccines. 2013;12(12):1417-30.
19. Russo JR, Moral R, Balogh GA, Mailo D, Russo IH. The protective role of pregnancy in breast cancer. Breast Cancer Res. 2005;7:131-42.
20. Peschken CA, Robinson DB, Hitchon CA, Smolik I, Hart D, Bernstein CN, et al. Pregnancy and the risk of rheumatoid arthritis in a highly predisposed North American native population. J Rheumatol. 2012;39(12):2253-60.
21. Russo IH, Koszalka M, Russo J. Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst. 1990;82:1286-9.
22. Duclos P. A global perspective on vaccine safety. Vaccine. 2004;22(15-16):2059-63.